학술논문
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
Document Type
Article
Author
Source
In ESMO Open June 2024 9(6)
Subject
Language
ISSN
2059-7029